1Steinberg, D (1997) Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 272, 20963–20966.
2Ehara, S, Veda, M, Naruko, T, et al. (2001) Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 103, 1955–1960.
3Toshima, S, Haserawa, A, Kurabayashi, M, et al. (2000) Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc Biol 20, 2243–2247.
4Henriksen, T, Mahoney, EM & Steinberg, D (1981) Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc Natl Acad Sci U S A 78, 6499–6503.
5Osterud, B & Bjorklid, E (2003) Role of monocytes in atherogenesis. Physiol Rev 83, 1069–1112.
6Hulthe, J & Faerberg, B (2002) Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study). Arterioscler Thromb Vasc Biol 22, 1162–1167.
7Wallenfeldt, K, Fagerberg, B, Wikstrand, J & Hulthe, J (2004) Oxidized low-density lipoprotein in plasma is a prognosis marker of subclinical atherosclerosis development in clinically healthy men. J Intern Med 256, 413–420.
8Ross, R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801–809.
9Ross, R (1999) Atherosclerosis – an inflammatory disease. N Engl J Med 340, 115–126.
10Shah, PK, Falk, E, Badimon, JJ, Fernández-Ortíz, A, Mailhae, A, Villareal-Levy, G, Fallon, JT, Rengstrom, J & Fuster, V (1995) Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 92, 1565–1569.
11Rajavashisth, TB, Andalibi, A, Territo, MC, Berliner, JA, Navab, M, Fogelman, AM & Lusis, AJ (1990) Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature 344, 254–257.
12Hamilton, TA, Major, JA & Chisolm, GM (1995) The effect of oxidized low density lipoproteins on inducible mouse macrophage gene expression are gene and stimulus dependent. J Clin Invest 95, 2020–2027.
13Yokode, M, Kita, T, Kikawa, Y, Ogonochi, T, Narumiya, S & Kawai, C (1988) Stimulated arachidonate metabolism during foam cell transformation of mouse peritoneal macrophages with oxidized low density lipoprotein. J Clin Invest 81, 720–729.
14Berliner, JA, Territo, MC, Sevanian, A, Ramin, S, Kim, JA, Bamshad, B, Esterson, M & Fogelman, AM (1990) Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 85, 1260–1266.
15Libby, P (1996) Atheroma: more than mush. Lancet 348, S4–S6.
16Akiba, S, Yoneda, Y, Ohno, S, Nemoto, M & Sato, T (2003) Oxidized LDL activates phospholipase A2 to supply fatty acids recognized for colesterol esterification. J Lipid Res 44, 1676–1685.
17Kris-Etherton, P, Eckel, RH, Howard, BV, St Jeor, S, Bazzarre, TL & Nutrition Committee, Population Science Committee and Clinical Science Committee of the American Heart Association (2001) AHA Science Advisory: Lyon Diet Heart Study. Benefits of a Mediterranean-style, National Cholesterol Education Program/American Heart Association Step I Dietary Pattern on Cardiovascular Disease. Circulation 103, 1823–1825.
18Keys, A, Menotti, A, Karvonen, MJ, et al. (1986) The diet and 15-year death rate on the seven countries study. Am J Epidemiol 124, 903–915.
19Moreno, JJ, Carbonell, T, Sánchez, T, Miret, S & Mitjavila, MT (2001) Olive oil decreases both oxidative stress and the production of arachidonic acid metabolites by the prostaglandin G/H synthase pathway in rat macrophages. J Nutr 131, 2145–2149.
20Moreno, JJ & Mitjavila, MT (2003) The degree of unsaturation of dietary fatty acids and the development of atherosclerosis. J Nutr Biochem 14, 182–195.
21Owen, RW, Mier, W, Giacosa, A, Hull, WE, Spiegelhalder, B & Bartsch, H (2000) Phenolic compounds and squalene in olive oils: the concentration and antioxidant potential of total phenols, simple phenols, secoroids, lignans and squalene. Food Chem Toxicol 38, 647–659.
22Marisilio, V, Campestre, C & Lanza, B (2001) Phenolic compounds changes during California-style ripe olive processing. Food Chem 74, 55–60.
23Visioli, F, Bellomo, G, Nantedoro, G & Galli, C (1995) Low density lipoprotein oxidation is inhibited in vitro by olive oil constituents. Atherosclerosis 117, 25–32.
24Cabello-Moruno, R, Perona, JS & Ruiz-Gutierrez, V (2007) Influence of minor components of olive oil on the composition and size of TRLs and on macrophage receptors involved in foam cell formation. Biochem Soc Trans 35, 470–471.
25Parcerisa, J, Casals, I, Boatella, J, Codony, R & Rafecas, M (2000) Analysis of olive and hazelnut oil mixtures by high-performance liquid chromatography-atmospheric pressure chemical ionisation mass spectrometry of triacylglycerols and gas chromatography of non-saponificable compounds. J Chromatogr 881, 149–158.
26Moreno, JJ (2003) Effect of olive oil minor components on oxidative stress and arachidonic acid mobilization and metabolism by macrophages RAW 264.7. Free Rad Biol Med 35, 1073–1081.
27Vivancos, M & Moreno, JJ (2005) β-Sitosterol modulates antioxidant enzyme response in RAW 264.7 macrophages. Free Rad Biol Med 39, 91–97.
28Bertelli, AA, Gozzini, A, Stradi, R, Stella, S & Bertelli, A (1998) Stability of resveratrol over time and in the various stages of grape transformation. Drugs Exp Clin Res 24, 207–211.
29Frankel, E, Waterhouse, A & Kinsella, J (1993) Inhibition of human LDL oxidation by resveratrol. Lancet 341, 1103–1104.
30Pace-Asciak, CR, Rounova, O, Hahn, SE, Diamandis, EP & Goldberg, DM (1996) Wine and grape juices as modulators of platelet aggregation in healthy human subjects. Clin Chem Acta 246, 163–182.
31Martínez, J & Moreno, JJ (2000) Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem Pharmacol 59, 865–870.
32Delmas, D, Jannin, B & Latruffe, N (2005) Resveratrol: preventing properties against vascular alterations and ageing. Mol Nutr Food Res 49, 377–395.
33Chung, BH, Segrest, JP, Ray, MJ, Brunzell, JD, Hokanson, JE, Krauss, RM, Beaudrie, K & Cone, JT (1986) Single vertical spin density gradient ultracentrifugation. Methods Enzymol 128, 181–209.
34Peterson, GL (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83, 346–356.
35Gieseg, SP & Esterbauer, H (1994) Low density lipoprotein is saturable by pro-oxidant copper. FEBS Lett 343, 188–194.
36Yagi, K (1976) A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 15, 212–216.
37Mapson, LW (1945) Influence of halides on the oxidation of ascorbic acid. Biochem J 39, 228–232.
38Martinez, J, Sanchez, T & Moreno, JJ (1997) Role of prostaglandin H synthase-2-mediated conversion of arachidonic acid in controlling 3T6 fibroblast growth. Am J Physiol 273, C1466–C1471.
39Innerarity, TL, Pitas, RE & Mahley, RW (1986) Lipoprotein receptor interactions. Methods Enzymol 129, 542–565.
40Beppu, M, Watanabe, M, Sunohara, M, Ohishi, K, Mishima, E, Kawashi, H, Fujii, M & Kikugawa, K (2002) Participation of the arachidonic acid cascade pathway in macrophage binding/uptake of oxidized low density lipoprotein. Biol Pharm Bull 25, 710–717.
41Abid, MR, Kachra, Z, Spokes, KC & Aired, WC (2000) NADPH oxidase activity is required for endothelial cell proliferation and migration. FEBS Lett 486, 252–256.
42Doehner, W, Schoene, N, Rauchhaus, M, Leyva-Leon, F, Pavitt, DV, Reaveley, DA, Schuler, G, Coats, AJ, Anker, SD & Hambrecht, R (2003) Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation 105, 1619–1624.
43Madamanchi, NR, Vendnov, A & Runge, MS (2005) Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 25, 29–38.
44Krieger, M & Herz, J (1994) Structures and functions of multiligand lipoprotein receptors: macrophage scavanger receptor and LDL receptor-related protein (LRP). Annu Rev Biochem 63, 343–346.
45Masella, R, Vari, R, D'Archivio, M, Di Benedetto, R, Matarrese, P, Malorni, W, Scazzocchio, B & Giovannini, C (2004) Extra virgin olive oil biophenols inhibit cell-mediated oxidation of LDL by increasing the mRNA transcription of glutathione-related enzymes. J Nutr 134, 785–791.
46Takaku, M, Wada, Y, Jinnnouchi, K, et al. (1999) An in vitro coculture model of transmigrant monocytes and foam cell formation. Arterioscler Thromb Vasc Biol 19, 2330–2339.
47Shashkin, P, Dragulev, B & Ley, K (2005) Macrophage differentiation to foam cells. Curr Pharm Des 11, 3061–3072.
48Rahaman, SO, Lennon, DJ, Febbraio, M, Rodrez, EA, Hazen, SL & Silverstein, RL (2006) A CD36-dependent signalling cascade is necessary for macrophage foam cell formation. Cell Metab 4, 211–221.
49Rouhanizadeh, M, Hwang, J, Clempus, RE, Marcu, L, Lassegue, B, Sevanian, A & Hsiai, TK (2005) Oxidized-1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphonylcholine induces vascular endothelial superoxide production. Implication of NADPH oxidase. Free Rad Biol Med 39, 1512–1522.
50Martínez, J & Moreno, JJ (1996) Influence of superoxide radical and hydrogen peroxide on arachidonic acid mobilization. Arch Biochem Biophys 336, 191–198.
51Martínez, J & Moreno, JJ (2001) Role of Ca2+-independent phospholipase A2 on arachidonic acid release induced by reactive oxygen species. Arch Biochem Biophys 392, 257–262.
52Martínez, J, Sanchez, T & Moreno, JJ (2000) Regulation of prostaglandin E2 production by the superoxide radical and nitric oxide in mouse peritoneal macrophages. Free Rad Res 32, 303–311.
53Lupo, G, Nicotra, A, Giurdanella, G, Anfuso, CD, Romeo, L, Biondi, G, Tirolo, C, Marchetti, B, Ragusa, N & Alberghina, M (2005) Activation of phospholipase A2 and MAP kinases by oxidized low-density lipoproteins in immortalized GP8.39 endothelial cells. Biochim Biophys Acta 1735, 135–150.
54Muroya, T, Ihara, Y, Ikeda, S, Yasuoka, C, Miyahara, Y, Urata, Y, Kondo, T & Kohno, S (2003) Oxidative modulation of NFkB signaling by oxidized low-density lipoprotein. Biochem Biophys Res Commun 309, 900–905.
55Matthys, KE, Van Hove, CE, Jorens, PG, Rosseneu, M, Marescau, B, Herman, AG & Bult, H (1996) Dual effects of oxidized low-density lipoprotein on immune-stimulated nitric oxide and prostaglandin release in macrophages. Eur J Pharmacol 298, 97–103.
56Capasso, R, Evidente, A, Avolio, S & Solla, F (1999) A highly convenient synthesis of hydroxytyrosol and its recovery from agricultural waste waters. J Agric Food Chem 47, 1745–1748.
57Covas, MI, Konstantinidou, V, Mysytaki, E, Fitó, M, Weinbrenner, T, de la Torre, R, Farre-Albadalejo, M & Lamuela-Raventos, R (2003) Postprandial effects of wine consumption on lipids and oxidative stress biomarkers. Drugs Exp Clin Res 29, 217–223.
58Covas, MI, de la Torre, K, Farré-Albaladejo, M, et al. (2005) Postprandial LDL phenolic content and LDL oxidation are modulated by olive oil phenolic compounds in humans. Free Rad Biol Med 40, 608–616.
59Hiltunen, TP & Yla-Herttuala, S (1998) Expression of lipoprotein receptors in atherosclerotic lesions. Atherosclerosis 137, S81–S88.
60Miles, EA, Wallace, FA & Calder, PC (2001) An olive oil-rich diet reduces scavenger receptor mRNA in murine macrophages. Br J Nutr 85, 185–191.
61Walle, T, Hsieh, F, DeLegge, MH, Oatis, JE Jr & Walle, UK (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32, 1377–1382.
62Weinbrenner, T, Fitó, M, Farré Albadalejo, M, Saez, GT, Rijken, P, Tormos, C, Coolen, S, De La Torre, R & Covas, MI (2004) Bioavailability of phenolic compounds from olive oil and oxidative/antioxidant status at postprandial state in healthy humans. Drugs Exp Clin Res 30, 207–212.
63Bertelli, AA, Giovannini, L, Stradi, R, Bertelli, A & Tillement, JP (1996) Urine and tissue levels of trans- and cis-resveratrol (3,4′,5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats. Int J Tissue React 18, 67–71.
64Sanders, DJ, Minter, HJ, Howes, D & Hepburn, PA (2000) The safety evaluation of phytosterol esters. Part 6. The comparative absorption and tissue distribution of phytosterols in the rat. Food Chem Toxicol 38, 485–491.
65Visioli, F, Galli, C, Bornet, F, Mattei, A, Patelli, R, Galli, G & Caruso, D (2000) Olive oil phenolics are dose-dependently absorbed in humans. FEBS Lett 468, 159–160.
66Miles, EA, Zoubouli, P & Calder, PC (2005) Differential anti-inflammatory effects of phenolic compounds from extra virgin olive oil identified in human whole blood cultures. Nutrition 21, 389–394.